Clotting Factors to Treat Thrombolysis-related Symptomatic Intracranial Hemorrhage in Acute Ischemic Stroke
- 9 December 2013
- journal article
- research article
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 23 (3) , e207-e214
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trialThe Lancet, 2012
- Relationship of National Institutes of Health Stroke Scale to 30‐Day Mortality in Medicare Beneficiaries With Acute Ischemic StrokeJournal of the American Heart Association, 2012
- Admission CT Perfusion Is an Independent Predictor of Hemorrhagic Transformation in Acute Stroke with Similar Accuracy to DWICerebrovascular Diseases, 2011
- Defining hematoma expansion in intracerebral hemorrhageNeurology, 2011
- Management of Thrombolysis-Associated Symptomatic Intracerebral HemorrhageArchives of Neurology, 2010
- The Penumbra Pivotal Stroke TrialStroke, 2009
- Mechanical Thrombectomy for Acute Ischemic StrokeStroke, 2008
- Size MattersStroke, 2007
- Survey of Emergency Physicians About Recombinant Tissue Plasminogen Activator for Acute Ischemic StrokeAnnals of Emergency Medicine, 2005
- Hemorrhagic Transformation Within 36 Hours of a Cerebral InfarctStroke, 1999